United States · FDA National Drug Code directory
Bortezomib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70511-161_2cc294fe-75e3-4ed9-8259-c6e5bc5e8286
- Product NDC
- 70511-161
- Form
- INJECTION
- Composition / generic term
- bortezomib
- Labeler
- MAIA Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220811
- Source listing expiry
- 20261231
Source-listed ingredients
- BORTEZOMIB — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INJECTION in 1 VIAL, SINGLE-DOSE (70511-161-05) · 70511-161-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →